United States · FDA National Drug Code directory

Olanzapine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0615-8244_23d2c50e-1be1-4357-bb2f-a9903ba4a43b
Product NDC
0615-8244
Form
TABLET, FILM COATED
Composition / generic term
Olanzapine
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Marketing category
ANDA
Marketing start / end (source format)
20140822
Source listing expiry
20261231

Source-listed ingredients

  • OLANZAPINE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8244-05) · 0615-8244-05
  • 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8244-39) · 0615-8244-39

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Olanzapine — United States | Molindra Medicines